Halozyme Therapeutics, Inc.

Ownership Transactions Reported by 14 Insiders

Symbol
HALO on Nasdaq
Location
12390 El Camino Real, San Diego, CA

Insiders trading volume in the past year

Halozyme Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Helen Torley PRESIDENT AND CEO, Director $49.9M -$6.26M -11.2% Feb 23, 2025
Michael J. LaBarre Svp, Chief Technical Officer $12.4M -$7.31M -37% Feb 25, 2025
Connie Matsui Director $9.91M Nov 29, 2024
Matthew L. Posard Director $4.19M -$2.7M -39.2% Aug 12, 2024
Nicole LaBrosse Svp, Chief Financial Officer $4.09M -$1.83M -30.9% Feb 23, 2025
Mark Howard Snyder Svp, Chief Legal Officer $3.99M Feb 23, 2025
Jean Pierre Bizzari Director $2.56M May 5, 2023
Jeffrey William Henderson Director $2.28M -$1.11M -32.7% Apr 1, 2025
Bernadette Connaughton Director $1.96M Apr 25, 2024
Masaru Matsuda SVP, General Counsel $1M Sep 4, 2021
Akiko Moni Miyashita Director $957K Apr 25, 2024
James M. Daly Director $896K Aug 11, 2023
Barbara Gayle Duncan Director $764K Apr 25, 2024
Mahesh Krishnan Director $250K Apr 25, 2024

Recent Insider Transactions by Companies or Individuals for Halozyme Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.